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Immunoglobulin superfamily member 4 (IGSF4) 
is a member of the intercellular adhesion mol-
ecule family (Shingai et al., 2003). It was first 
characterized as a tumor suppressor in non-
small  cell  lung  cancer  and  termed  TSLC1 
(Murakami, 2005). Later, it was found to have 
roles in the adhesion of spermatogenic cells to 
Sertoli  cells  (van  der  Weyden  et  al.,  2006; 
Yamada et al., 2006) and mast cells to fibro-
blasts (Ito et al., 2003, 2004; Koma et al., 
2005) and was termed SgIGSF. Other research-
ers  revealed  that  IGSF4  drives  the  synaptic 
formation of neural cells and termed it SynCAM 
(Ohta et al., 2005). Three extracellular do-
mains of IGSF4 mediate homophilic or het-
erophilic interactions independently of Ca2+ 
(Watabe et al., 2003). The cytoplasmic (CT) 
domain contains the binding motifs connect-
ing  to  actin  fibers,  but  the  function  of  the 
transmembrane (TM) domain is not known. 
Furthermore, on APCs, IGSF4 serves as a ligand 
of CRTAM (MHC class I–restricted T cell–
associated molecule), a receptor primarily ex-
pressed on activated cytotoxic T cells (Arase 
et al., 2005), and regulates IFN- and IL-22 
expression by activated CD8+ T cells (Yeh 
et al., 2008). However, its function with re-
gard to T cells has not been addressed.
The TCR is the key structure recognizing 
its  cognate  peptide  in  an  MHC  molecule. 
However, it is not sufficient to induce intra-
cellular signaling cascades and the subsequent 
T cell activation. Therefore, various integral 
membrane proteins are associated with or func-
tionally involved in TCR-mediated signal trans-
duction. For example, invariant chains such 
as CD3, CD3, CD3, and TCR -chains, 
CORRESPONDENCE  
Chang-Duk Jun: 
cdjun@gist.ac.kr
Abbreviations used: c-SMAC, 
central SMAC; CT, cytoplas-
mic; DP, double positive; ES, 
embryonic stem; mRNA, mes-
senger RNA; PLL, poly-l-
lysine; SEB, Staphylococcus 
enterotoxin B; SEE, Staphylococ-
cus enterotoxin E; shRNA, 
short hairpin RNA; siRNA, 
small interfering RNA; SMAC, 
supramolecular activation cluster; 
TM, transmembrane.
IGSF4 is a novel TCR -chain–interacting 
protein that enhances TCR-mediated 
signaling
Hye-Ran Kim,1,2 Byeong-Hun Jeon,1,2 Hyun-Su Lee,1,2 Sin-Hyeog Im,1,2 
Masatake Araki,3 Kimi Araki,3 Ken-ichi Yamamura,3 Suck-Chei Choi,4  
Do-Sim Park,5 and Chang-Duk Jun1,2
1Immune Synapse Research Center and 2Cell Dynamics Research Center, School of Life Sciences, Gwangju Institute  
of Science and Technology, Gwangju 500-712, South Korea
3Institute of Resource Development and Analysis, Kumamoto University, Honjo, Kumamoto 860-0811, Japan
4Department of Internal Medicine and 5Department of Laboratory Medicine, School of Medicine, Wonkwang University,  
Iksan 570-749, South Korea
Immunoglobulin superfamily member 4 (IGSF4) is a known ligand of CRTAM, a receptor 
expressed in activated NKT and CD8+ T cells, but its function in T cell immunity has not 
been elucidated. In this study, we show that IGSF4 directly interacts with the T cell recep-
tor (TCR) -chain and enhances TCR signaling by enhancing -chain phosphorylation. 
Ectopic overexpression of IGSF4 enhances TCR-mediated T cell activation. In contrast, 
IGSF4 knockdown shows a dramatic decrease in markers associated with T cell activation 
compared with those in control small interfering RNA. The transmembrane domain is 
essential for TCR -chain association and clustering to the immunological synapse, and the 
ectodomain is associated with T cell interaction with antigen-presenting cells (APCs). 
IGSF4-deficient mice have impaired TCR-mediated thymocyte selection and maturation. 
Furthermore, these mice reveal attenuated effector T cell functions accompanied by defec-
tive TCR signaling. Collectively, the results indicate that IGSF4 plays a central role in T cell 
functioning by dual independent mechanisms, control of TCR signaling and control of  
T cell–APC interaction.
© 2011 Kim et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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bottom right). These results clearly demonstrate that IGSF4 
is expressed in T cells, and its expression is controlled during 
T cell activation.
We next determined whether IGSF4 knockdown in-
fluences  T cell functions. Compared with control small inter-
fering RNA (siRNA), siRNA targeting IGSF4 significantly 
reduced IGSF4 expression in Jurkat T cells (Fig. 1 C, left). 
Interestingly, a dramatic reduction in IL-2 mRNA levels 
was  observed  in  Jurkat T  cells  transfected  with  IGSF4 
siRNA after stimulation with anti-CD3/28 or incubation 
with Staphylococcus enterotoxin E (SEE)–pulsed Raji B cells 
(Fig. 1 C, left). A significant decrease in IL-2 expression 
was also observed in human PBLs (Fig. 1 C, middle). To test 
the antigen-specific T cell response, we also used splenic 
CD3+ T cells from TCR transgenic DO11.10 mice and 
found a dramatic reduction in mouse IL-2 mRNA levels 
in  the  IGSF4  short  hairpin  RNA  (shRNA)–transfected 
cells  incubated  with  OVA  peptide–loaded  A20B  cells   
(Fig. 1 C, right).
We also established Jurkat T cells overexpressing either 
GFP (J-GFP) or WT IGSF4_GFP (J-IGSF4_GFP) by lentiviral 
transduction (Fig. 1 D, top). J-IGSF4_GFP cells had a signifi-
cant increase in IL-2 mRNA levels compared with J-GFP 
cells after stimulation with anti-CD3/28 or incubation with 
SEE-pulsed Raji B cells. In contrast, no significant difference 
was observed between J-GFP and J-IGSF4_GFP cells stimu-
lated with PMA/A23187 (Fig. 1 D, bottom). These results 
strongly suggest a positive role of IGSF4 in TCR-mediated 
T cell activation.
IGSF4 localizes at the c-SMAC  
in the immunological synapse
Many T cell–regulating molecules are located in a specialized 
junctional structure referred to as the immunological synapse 
(Monks et al., 1998; Grakoui et al., 1999) during T cell con-
tact with APCs. We next explored the localization of IGSF4 
during Jurkat T cell interaction with SEE-pulsed Raji B cells. 
In the absence of SEE, IGSF4 was most prominent on the 
membrane surface and was strongly relocated at the T cell– 
T cell contact sites (>95%; Fig. 2 A), suggesting that IGSF4 on 
one T cell induces homotypic trans-interaction with the 
same molecule on the neighboring T cell. Interestingly, relo-
cation of IGSF4 was also observed at immature immunological 
synapses in the absence of SEE (28 ± 7%; Fig. 2 A). The re-
location and concentration of IGSF4 was more obvious 
during maturation of the immunological synapse in the 
presence of SEE (73 ± 5%; Video 1). These results dem-
onstrate that IGSF4 has a potential role in the early to late 
phase of T cell activation.
To identify its specific location, we performed a colocal-
ization study of IGSF4 with other immunological syn-
apse molecules such as CD3, CD45, LFA-1, and ICAM-1 
in T cell–APC conjugates. IGSF4 predominantly colocal-
ized with CD3, a key molecule of the c-SMAC, and was 
clearly  distinguishable  from  LFA-1,  a  peripheral  SMAC 
molecule. On the basis of these observations, we considered 
constituting the TCR complex, initiate a series of intra-
cellular signaling cascades (Lin and Weiss, 2001; Le Deist et al., 
2007). Surface antigens such as CD2, CD4, or CD8 and 
CD5, which are physically associated with the TCR com-
plex (Beyers et al., 1992), are required for efficient signal 
transduction (Horejsí et al., 2004). Although co-stimulatory 
molecules such as B7/CD28, TNFR/TNF, CD58/CD2, 
and ICAM-1/LFA-1 are not directly associated with the 
TCR complex, they provide secondary signals for T cell 
activation (Wingren et al., 1995). Lastly, membrane pro-
teins providing multiple docking sites for cytosolic signaling 
and effector molecules have roles in the regulation of T cell 
functions  (Zhang  and  Samelson,  2000).  These  proteins, 
termed TRAPs (TM adaptor proteins), include LAT (linker 
for activation of T cells; Martelli et al., 2000; Wange, 2000), 
TRIM (TCR-interacting molecule; Bruyns et al., 1998; 
Kirchgessner et al., 2001), PAG (protein associated with 
GEMs; Davidson et al., 2003; Maksumova et al., 2005), 
NTAL (non–T cell activation linker; Brdicka et al., 2002), 
LIME  (LCK-interacting  membrane  protein;  Hur  et  al., 
2003), and SIT (SH2-domain–containing protein tyrosine 
phosphatase [SHP2]–interacting TRAP; Marie-Cardine et al., 
1999; Posevitz et al., 2008). However, no member of the 
intercellular adhesion molecule family that physically asso-
ciates with the subunits of the TCR complex and modu-
lates TCR signaling has been reported so far.
Interestingly, in this study, we found that IGSF4 messen-
ger RNA (mRNA) and its protein product are expressed in 
all human and mouse T cells. Furthermore, we found that 
IGSF4, even without the ectodomain, localizes at the central 
supramolecular activation cluster (SMAC [c-SMAC]) in the 
immunological synapse during T cell–APC interaction. This 
finding raised the question whether IGSF4 serves as a physi-
cal partner with the TCR complex or at least modulates 
TCR signaling in an adhesion-independent way. Because 
IGSF4  is  an  intercellular  adhesion  molecule  expressed  on 
both T cells and APCs, we also addressed whether IGSF4 has 
an adhesion-dependent co-stimulatory function through homo-
typic or heterotypic interactions with ligands on APCs. In 
this study, we provide evidence that IGSF4 is an important 
molecule for T cell functioning.
RESULTS
IGSF4 is expressed in human and mouse T cells  
and positively regulates T cell responses
IGSF4 is reportedly not detectable in normal CD4+ T cells 
and some human T cell lines (Sasaki et al., 2005). However, 
we detected IGSF4 not only in immune function–related 
tissues (spleen, thymus, and lymph node) but also in human 
T cell lines (Fig. 1 A, top and bottom left) and all human 
and mouse T cell subsets including CD4+ and CD8+ T cells, 
B cells (CD19+), and DCs (CD11c+; Fig. 1 A, bottom right). 
In  addition,  anti-CD3/28  or  PMA/A23187  stimulation 
slightly increased both the mRNA and protein levels of 
IGSF4 in Jurkat T cells (Fig. 1 B, top), human PBLs (Fig. 1 B, 
bottom left), and mouse splenic CD3+ T cells (Fig. 1 B,   JEM Vol. 208, No. 12 
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Figure 1.  IGSF4 is expressed in human 
and mouse T cells and positively regu-
lates T cell responses. (A) Western blot and 
RT-PCR analyses. (top) Tissue distribution of 
IGSF4 in 8-wk-old mice. IGSF4 expression in 
T cell lines (bottom left) and purified mouse 
or human T cell subsets (bottom right).  
#, clone number; SP, splenic CD3+ T cells.  
(B) Jurkat T cells (top), human PBLs (bottom 
left), and mouse splenic CD3+ T cells (bottom 
right) were stimulated for the indicated 
times with anti-CD3/28, and the expression 
of IGSF4 or IL-2 was assessed by quantita-
tive PCR and flow cytometric analyses (top), 
RT-PCR analysis (bottom left), and Western 
blot analysis (bottom right). (A and B) The 
data are representative of three independent 
experiments. (C) Jurkat T cells (left) and  
human PBLs (middle) were transfected with 
either 70 µM of scrambled (SC) siRNA or 
siRNA targeting IGSF4. IGSF4 expression was 
measured after 48 h of transfection (top). 
Stimulation of cells and IL-2 mRNA mea-
surements were performed as described in B. 
The results are the mean ± SD of triplicate 
experiments. (right) Purified splenic CD3+  
T cells from TCR transgenic DO11.10 mice 
were transfected with 1 µg/100 µl shRNA 
targeting IGSF4. The IGSF4 knockdown  
efficiency was analyzed after 48 h of transfec-
tion (top). The cells were coincubated with 
50 ng/ml OVA–pulsed A20 mouse B cells, 
and the IL-2 mRNA levels were measured. 
The results are the mean ± SD of triplicate 
experiments. (D, top) Establishment of Jurkat 
T cells overexpressing GFP or WT-IGSF4_GFP 
by lentiviral transduction. The efficiency of 
viral infection was determined by Western 
blot and flow cytometric analyses. IB, immuno-
blot. (bottom) The cells were then stimulated 
with SEE-pulsed Raji B cells, anti-CD3/28,  
or PMA/A23187 for the indicated time.  
IL-2 mRNA levels were assessed by RT-PCR 
(blots) and real-time quantitative PCR 
(graphs) analyses. The results are the  
mean ± SD of triplicate experiments. Mo-
lecular mass (M) is indicated in kilodaltons. 
EV, empty vector.
the  potential  mechanisms  of  IGSF4  in T  cell  function. 
Given  that  IGSF4  is  an  intercellular  adhesion  molecule 
that is also expressed in APCs including B cells and DCs 
(Fig. 1 A), an adhesion-dependent co-
stimulatory function through homo-
typic or heterotypic interactions with 
ligands on APCs is possible. Because 
IGSF4 localized at the c-SMAC and 
highly  colocalized  with  CD3,  it  is 
possible that IGSF4 performs an en-
hancer function in association with the molecules in the 
TCR signaling platform. Alternatively, these two mecha-
nisms could coexist independently.2548 IGSF4 enhances T cell activation | Kim et al.
We next questioned whether the increased IL-2 expres-
sion in J-IGSF4_GFP cells corresponds to the increased   
T cell adhesion to APCs. To this end, three Ig domains of 
IGSF4 were exchanged with domains 3–5 (D3–5) of ICAM-
1 and expressed in Jurkat T cells (Fig. 3 C). Because D3–5 
of ICAM-1 have no ligand-binding site on B cells, this 
ICAM-1–IGSF4 chimera (IC1_IGSF4) is functionally null. 
Polarization of IGSF4 at the cell–cell contact region (ar-
rows) disappeared in J-IC1_IGSF4_GFP cells (95 ± 4% of 
IGSF4 vs. 3 ± 2% of IC1_IGSF4; Fig. 3 C). Accordingly, 
IL-2  expression  reduced  in  these  cells  compared  with   
J-IGSF4_GFP cells, suggesting that an adhesion-dependent 
function is an important mechanism for IGSF4-mediated 
T cell activation. Interestingly, however, we observed that 
the levels of IL-2 mRNA in J-IC1_IGSF4_GFP cells did 
not reduce to those in J-GFP cells (Fig. 3 D). This result 
suggests the existence of another mechanism for T cell acti-
vation by IGSF4.
IGSF4 accumulation in the c-SMAC depends  
on the TM domain
To completely exclude the adhesion-dependent mecha-
nism by the IGSF4 ectodomain, J-IGSF4_GFP cells were 
placed on coverslips coated with poly-l-lysine (PLL) or 
anti-CD3. Confocal microscopy revealed that WT IGSF4_
GFP significantly accumulated at the bottom of only the 
anti-CD3–coated coverslips (Fig. 4 A, left). The same results 
were obtained with anti-CD3/28–coated microbeads (Fig. 4 A, 
right top). These results suggest that IGSF4 relocation to 
the  c-SMAC  is  independent  off  receptor–ligand  inter-
action but requires other domains. Supporting this view, 
colchicine, a microtubule inhibitor, almost completely in-
hibited IGSF4 relocation to the c-SMAC (Fig. 4 A, right 
bottom), suggesting the involvement of the CT or TM 
domain rather than receptor–ligand interaction.
To define the functional domain of IGSF4, several de-
letion mutants were constructed and expressed in Jurkat   
T cells. GFP was fused at the end of each construct to facili-
tate visualization by confocal microscopy. Interestingly, a 
partial deletion of CT (PDZ) or deletion of the entire CT 
domain (CT) of IGSF4 (Fig. 4 B, top left) had little effect 
on its subcellular localization on the membrane (Fig. 4 B, 
top  right),  accumulation  at  the  cell–cell  contact  region 
(Fig. 4 B, bottom left) and anti-CD3–coated coverslips 
(Fig. 4 B, bottom middle), or IL-2 expression in response to 
anti-CD3/28 (Fig. 4 B, bottom right). These results dem-
onstrate that the CT domain of IGSF4 is not required for 
localization of IGSF4 on the membrane and is not the func-
tional domain.
We therefore examined the function of the TM domain. 
We used the domain-swapping strategy to understand the ap-
parent role of the TM domain in IGSF4-mediated T cell acti-
vation. CD43 was selected as this protein is known to be 
excluded from the c-SMAC during immunological synapse 
formation (Fig. 4 B, top left; Delon et al., 2001). Exchange of 
the TM domain of IGSF4 to the TM domain of CD43 
IGSF4 enhances T cell–T cell or T cell–APC adhesion,  
and its ectodomain mutation reduces T cell activation
We first tested the adhesion-dependent co-stimulatory func-
tion. As expected, J-GFP cells did not prominently aggregate 
under the normal culture condition. In contrast, J-IGSF4_
GFP cells aggregated (Fig. 3 A), with intense aggregation 
after TCR engagement with anti-CD3/28 (Fig. 3 A). T cell 
adhesion to APCs was also examined in the absence or pres-
ence of the superantigen. Quantitative analysis revealed that 
J-IGSF4_GFP cells had significantly increased conjugate for-
mation  regardless  of  SEE  (Fig.  3  B),  demonstrating  that 
IGSF4 mediates T cell adhesion to APCs.
Figure 2.  IGSF4 localizes at the c-SMAC in the immunological 
synapse. (A) J-IGSF4_GFP cells were incubated with Raji B cells stained 
with orange CMRA in the presence or absence of SEE. Arrowheads indi-
cate the polarized IGSF4 (green) at the cell–cell contact sites. The percent-
age of T–T or T–B conjugates with surface IGSF4 relocation at the contact 
zone relative to the total number of conjugates in the absence or pres-
ence of SEE was analyzed from a total of 150 conjugates of each cat-
egory. The results are the mean ± SD of triplicate experiments. The boxed 
areas (blue and orange) are represented as zoomed images in the right 
panels. (B) J-IGSF4_GFP cells were stained with anti-CD3 (cy5), anti-CD45 
(cy5), or anti–LFA-1 (cy5) Fabs and then incubated with SEE-loaded Raji  
B cells stained with anti–ICAM-1 (cy3) Fab. See also Video 1. The data are 
representative of four independent experiments. The panels on the right 
represent zoomed images of the boxed areas (yellow) indicated in the 
differential interference contrast images. Bars, 10 µm.JEM Vol. 208, No. 12 
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and Jurkat T cells. The membrane localization was similar 
to the WT (Fig. 4 B, top right). In addition, this mutant 
accumulated  at  the  T  cell–APC  contact  sites  and  anti-
CD3–coated surfaces (Fig. 4 B, bottom left and middle). 
Consequently, J-IGSF4/EXT_GFP cells had higher levels 
of IL-2 expression than J-GFP cells, but the expression 
levels were lower than those in J-IGSF4_GFP cells (Fig. 4 B, 
bottom right). In contrast, despite a similar cellular local-
ization  pattern  (Fig.  4  B,  top  right),  the  mutant  with 
CD43TM (IGSF4/EXT/CD43TM) was not recruited to 
the c-SMAC and anti-CD3–coated surfaces (Fig. 4 B, bottom 
left and middle). Finally, no difference in IL-2 expression 
was observed compared with that in J-GFP cells (Fig. 4 B, 
bottom  right).  Together,  these  re-
sults  strongly  suggest  that  the  TM 
domain of IGSF4 is essential and suf-
ficient for recruitment of IGSF4 to the   
c-SMAC and is therefore important 
for T cell activation.
generated  a  mutant  termed  IGSF4/CD43TM.  Despite  the 
similar cellular localization pattern, interestingly, this mutant 
revealed less accumulation at the T cell–APC contact sites 
(Fig. 4 B, top right and bottom left) and anti-CD3–coated 
surfaces (Fig. 4 B, bottom middle). In addition, IL-2 expression 
in response to anti-CD3/28 was significantly reduced in Jurkat 
T cells expressing IGSF4/CD43TM compared with WT 
IGSF4 (Fig. 4 B, bottom right).
The obtained result suggested that the TM domain may 
have its own role in T cell activation. Therefore, we de-
leted the ectodomain and the signal sequence was directly 
linked to the TM domain, thereby enabling the expression 
of only the TM and CT domains (IGSF4/EXT) in 293T 
Figure 3.  IGSF4 enhances T cell–T cell 
and T cell–APC adhesions by ectodomain 
interaction. (A) J-GFP or J-IGSF4_GFP cells 
(2 × 105 cells/well) were cultured in the pres-
ence or absence of anti-CD3/28 for 3 h and 
photographed. Quantitation of cell aggrega-
tion was determined as described in Materi-
als and methods. The results are the mean ± 
SD of six experiments. *, P < 0.05 versus  
J-GFP cells without stimulation. **, P < 0.05 
versus J-GFP cells with anti-CD3/28 stimula-
tion. DIC, differential interference contrast; 
EV, empty vector. (B) A representative conju-
gate formation profile with T cells and Raji  
B cells and the percentage of DP cells (blue) are 
shown in the flow cytometric plot and bar 
graph, respectively. The results are the mean ± 
SD of triplicate experiments. *, P < 0.05 versus 
J-GFP cells without stimulation. **, P < 0.05 
versus J-GFP cells with SEE-pulsed Raji  
B cells. (C and D) Domain swapping from the 
IGSF4 ectodomain to ICAM-1 D3–5 in IGSF4-
mediated T cell activation. (C, top) Arrows 
indicate the relocation of IGSF4 at the cell–
cell contact regions in Jurkat T cells express-
ing WT-IGSF4_GFP but not IC1_IGSF4_GFP. 
(bottom) Schematic illustration showing 
swapped region of IGSF4/EXTD with ICAM1/
D3-5. Quantitation of IGSF4 or IC1_IGSF4 
relocation was performed as described in  
Fig. 2 A. The results are the mean ± SD of 
four experiments. IG4, IGSF4; IC1, ICAM-1 
D3–5. (D) These cells were stimulated with 
SEE-pulsed Raji B cells, and the IL-2 mRNA 
levels were assessed by real-time quantitative 
PCR. The results are the mean ± SD of tripli-
cate experiments. *, P < 0.05, as compared 
with cells expressing WT-IGSF4. Bars: (A) 100 µm;   
(C) 10 µm.2550 IGSF4 enhances T cell activation | Kim et al.
Figure 4.  IGSF4 recruitment to the immunological synapse is independent off receptor–ligand interaction but is mediated by the TM  
domain. (A, left) J-IGSF4_GFP cells were placed on chambered coverslips coated with PLL or anti-CD3. Confocal images were obtained and reconstituted 
to the three-dimensional images by the FLUOVIEW program. The fluorescent intensity caused by the accumulation at the PLL or anti-CD3–coated surface 
was quantified. Note, a = contact region and b = opposite region. Each dot represents a single measurement, and at least 50 cells were examined.  JEM Vol. 208, No. 12 
Article
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Next, we wondered whether the association of IGSF4 
with the -chain influences the phosphorylation of down-
stream  signaling  molecules  upon  TCR/CD3  stimulation.   
J-IGSF4_GFP cells showed increased levels of phospho–-chain 
(p– -chain) compared with J-GFP cells (Fig. 5 B, top). Con-
sistently, downstream proximal kinases such as Lck and Zap70 
and distal MAP kinases such as ERK and p38 kinase were 
highly phosphorylated in J-IGSF4_GFP cells compared with 
J-GFP cells (Fig. 5 C). Interestingly, the level of p–-chain 
was  significantly  increased  in  J-IGSF4/EXT_GFP  cells 
compared with the levels in J-GFP and J-EXT/CD43TM_
GFP cells (Fig. 5 B, bottom). These results demonstrate that 
binding of IGSF4 to the -chain through the TM domain is 
critical for enhancing -chain activity and that of its follow-
ing proximal and distal kinases.
IGSF4-deficient mice have defective T cell functioning
To obtain insight into the physiological significance of IGSF4 
in T cell immunity, we generated mice deficient in IGSF4 by 
using gene trap methods (strain name: B6;CB-Cadm1Gt(pU-
21W)34Imeg). Insertion of the trap vector in the first intron 
region of IGSF4 was confirmed by PCR analysis using ge-
nomic DNA from ear tissues (Fig. 6, A and B). However, we 
found a small amount of IGSF4 protein in T cells from 
IGSF4-deficient mice (see Fig. 8 A), suggesting inefficient 
use of the splice acceptor site by which a small amount of 
normal mRNA can be produced, as described previously   
(Li et al., 2010). Therefore, the insertion was considered a 
hypomorphic allele and homozygous mice were designated 
GT/GT. Interestingly, the homozygous mice were smaller 
and lighter than the WT mice (Fig. 6 C), implying that 
IGSF4 may also be involved in the developmental process or 
bone development.
As TCR -chain signaling is critical not only for effector 
functions but also for T cell development (Shores and Love, 
1997), we first observed whether IGSF4-deficient mice have 
developmental defects in terms of thymocyte selection. Intra-
thymic T cell maturation involves sequential differentiation 
stages that can be distinguished on the basis of CD4 and CD8 
coreceptor  expression  (Shortman,  1992).  Interestingly,  the 
number and percentage of CD4+ and CD8+ single-positive 
cells were much lower in the thymus of IGSF4GT/GT mice 
IGSF4 associates with the TCR -chain through the TM 
domain and boosts -chain–linked signaling cascades
The finding that the TM domain is essential for IGSF4 relo-
cation to the c-SMAC is intriguing because IGSF4 may in-
teract  with  molecules  in  the  c-SMAC  through  TM–TM 
interactions. To identify the physically interacting partners of 
IGSF4 in the c-SMAC, coimmunoprecipitation assay was 
performed with anti-GFP (for IGSF4), and immunoblotting 
was performed with antibodies against potential candidate 
proteins, including TCR  and , CD3, CD3, CD3, 
TCR , Zap70, and Lck. IGSF4 strongly interacted with the 
-chain under both resting and activated conditions. The inter-
action was also confirmed by reverse configuration: pull-
down of the -chain and immunoblotting of endogenous 
IGSF4 (Fig. 5 A, top left and right). In parallel experiments, 
however, IGSF4 failed to interact with other components of 
the TCR, including TCR  and , CD3, and CD3 
(Fig. 5 A, bottom left), suggesting that the interaction of 
IGSF4 is -chain specific among the components of the TCR 
complex. Only a trace amount of CD3 was recovered in the 
IGSF4 immunoprecipitates under the mild detergent (0.3% 
CHAPS) condition (Fig. 5 A, bottom left). To further test 
whether IGSF4 binding to -chain occurs in the absence of 
other components of the TCR complex, cDNA constructs 
encoding WT-IGSF4_GFP and _RFP were cotransfected 
in 293T cells, and then a coimmunoprecipitation assay was 
performed with anti-GFP (for IGSF4) and anti-TCR -chain. 
The results strongly demonstrated that IGSF4 directly associ-
ates with the TCR -chain (Fig. 5 A, middle left). In sup-
porting this view, WT-IGSF4 was highly colocalized with 
the TCR _RFP (Fig. 5 A, middle right). Low amounts of 
Zap70 and Lck were also detectable in the IGSF4 immuno-
precipitates under the mild-detergent condition only after 
stimulation  with  anti-CD3/28,  suggesting  recruitments  of 
Zap70 and Lck to the phosphorylated ITAMs in the -chain 
(Fig. 5 A, top left). Interestingly, WT IGSF4 and mutant 
IGSF4 containing the TM domain could interact only with 
the -chain (Fig. 5 A, bottom right), demonstrating that the 
TM domain is essential for the association with the -chain 
and therefore localization to the c-SMAC. In addition, these 
results strongly demonstrate that IGSF4 is involved in TCR/
CD3-mediated first signals.
The data are representative of two independent experiments. (right) J-IGSF4_GFP cells were incubated with either BSA or anti-CD3/28–coated beads (top) 
or SEE-pulsed Raji B cells in the presence or absence of 1 µg/ml colchicine (Col) for 30 min (bottom), and live-cell imaging was performed. Arrowheads 
indicate IGSF4 accumulation at the synapse sites. Boxed areas (green) are shown as magnified images in the micrographs below. The fluorescent intensity 
caused by the accumulation at the T cell–APC contact site was quantified. Data analysis was performed as described in A (left). The data are representa-
tive of two independent experiments. DIC, differential interference contrast. (B, top left) Schematic diagram showing deletion and swapping mutants of 
IGSF4 (top). T cell–B cell conjugates were stained with anti-CD43 (FITC) and anti-CD3 (cy3). The arrowhead reveals the exclusion of CD43 from the immuno-
logical synapse (bottom). (top right) Localization pattern of each mutant of IGSF4 in HEK293T and Jurkat T cells. (bottom left and middle) Jurkat T cells 
expressing IGSF4_GFP or mutants (IGSF4PDZ, IGSF4CT, IGSF4/CD43TM, IGSF4/EXT, or IGSF4/EXT/CD43TM) were either incubated with SEE-loaded 
Raji B cells (bottom left) or placed on coverslips coated with PLL or anti-CD3 (bottom middle), and confocal analysis was performed. At least 20 z-stack 
images were reconstituted into a three-dimensional image for the bottom middle panel. Intensity represents accumulation from low (blue) to high (red). 
Quantitation and data analysis were performed as described in A (left). The data are representative of four independent experiments. (bottom right) Real-
time quantitative PCR analysis of IL-2 mRNA expression in response to anti-CD3/28. *, P < 0.05; and +, P < 0.01, as compared with cells expressing  
WT-IGSF4. The results are the mean ± SD of triplicate experiments. EV, empty vector. (A and B) Horizontal bars indicate the mean. Bars, 10 µm.
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collectively suggested that the deletion of IGSF4 results in a 
substantial block in thymocyte development at the DP stage.
TCR -chain gene rearrangement and surface expression 
are critical for thymocyte development (Mombaerts et al., 
1992). Flow cytometry showed that 
IGSF4GT/GT  thymocytes  included 
fewer TCR-hi cells than did WT thy-
mocytes (Fig. 7 B). In contrast, the pro-
portion of TCR-lo cells in IGSF4GT/GT 
thymuses was normal (Fig. 7 B). In 
addition to influencing TCR -chain 
than IGSF4+/+ mice (Fig. 7 A). However, the double-positive 
(DP) cells were higher in the thymus of IGSF4GT/GT mice than 
IGSF4+/+ mice (Fig. 7 A). Because we found no significant 
difference  in  the  double-negative  population,  these  data 
Figure 5.  IGSF4 associates with the TCR 
-chain through the TM domain and 
boosts TCR-mediated signal transduction. 
(A, top) J-GFP or J-IGSF4_GFP cells were incu-
bated for 30 min with or without anti-
CD3/28. Cell lysates were immunoprecipitated 
with anti-GFP (top left) or anti–TCR -chain 
(top right) and then immunoblotted with anti-
bodies against the indicated molecules (-chain, 
Lck, Zap70, or IGSF4). (middle) HEK293T cells 
were cotransfected with WT-IGSF4_GFP  
and TCR _RFP, and then immunoprecipita-
tion (IP) and immunoblotting (IB) were per-
formed as in the top left blots. Confocal 
images show surface localization of IGSF4_
GFP and TCR _RFP. The boxed area (yellow)  
is represented as zoomed images in the right 
and bottom micrographs. Bar, 10 µm. (bottom 
left) J-GFP or J-IGSF4_GFP cell pellets were 
lysed, immunoprecipitated with anti-GFP, and 
then immunoblotted with antibodies against 
the indicated molecules (TCR  and , CD3, 
CD3, CD3, TCR , and GFP). Total lysates 
were also immunoblotted with the same anti-
bodies indicated above. The data are represen-
tative of two independent experiments. 
(bottom right) Immunoprecipitation and 
immunoblotting of Jurkat T cells expressing GFP, 
WT-IGSF4_GFP, or the indicated mutants 
(CT, EXT, CD43TM, and EXT/CD43TM) as 
in A (top left). The data are representative of 
at least three independent experiments. EV, 
empty vector; IG4, IGSF4. (B) Jurkat T cells 
expressing GFP, WT-IGSF4_GFP, or mutant 
IGSF4 (CT, EXT, and EXT/CD43TM) were 
stimulated with plate-bound anti-CD3 for the 
indicated time. The cells lysates were immuno-
blotted by using antibodies against phos-
phorylated (p) and total (t) -chain. The data 
are representative of three independent ex-
periments. (C) J-GFP or J-IGSF4_GFP cells 
were stimulated with plate-bound anti-CD3 
for the indicated time. The cell lysates were 
immunoblotted for the phosphorylated and 
total forms of Lck, Zap70, ERK, and p38  
kinase. The data are representative of at least 
three independent experiments. Molecular 
mass (M) is indicated in kilodaltons.JEM Vol. 208, No. 12 
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IGSF4GT/GT  mice  and  compared  it 
with WT. Splenic CD3+ T cells from 
IGSF4GT/GT mice had dramatically re-
duced phosphorylation of the -chain, 
downstream kinases Lck and Zap70, and the foregoing sig-
naling pathways of ERK and p38 kinase upon TCR stimula-
tion with anti-mCD3/28 (Fig. 8 C). We also examined the 
membrane proximal signal during T cell contact with APCs. 
To this end, allogeneic DC (IGSF4+/+) mice were isolated, 
pulsed with Staphylococcus enterotoxin B (SEB), and incu-
bated with splenic CD3+ T cells isolated from IGSF4+/+ or 
IGSF4GT/GT mice. As shown in Fig. 8 D, p-tyrosine staining 
at the T cell–APC contact regions was significantly reduced 
in T cells from IGSF4GT/GT mice compared with those from 
IGSF4+/+ mice. These results suggest that, in the absence of 
IGSF4, TCR cross-linking does not fully stimulate the most 
immediate as well as downstream distal signaling pathways.
Because the ectodomain is also important for T cell–APC 
interaction (Fig. 3), we performed a conjugation assay of 
mouse T cells with SEB-loaded DCs or B cells. Multiple WT 
T cells formed immune synapses with DCs and B cells 
(Fig. 8 E). In contrast, conjugate formation was hardly found 
in IGSF4-deficient T cells (Fig. 8 E, left).
Finally, we assessed the effector T cell functions by mea-
suring cytokine expressions in CD4+ and CD8+ T cells. As 
the proliferation of purified T cells from IGSF4GT/GT mice 
was significantly impaired under the condition with anti-
mCD3/28 (Fig. 8 F), presumably by defective TCR signal-
ing, we directly stimulated purified CD4+ and CD8+ T cells 
with anti-mCD3/28 or PMA/A23187. ELISA demonstrated 
expression,  TCR  engagement  initiates  intracellular  signals 
that induce the expression of thymocyte positive selection 
and maturation markers, such as CD69 and CD5 (Fowlkes 
et al., 1985). The surface expression of CD5 and CD69 was 
much lower on IGSF4GT/GT thymocytes than WT thymo-
cytes (Fig. 7 B), suggesting that TCR-mediated positive se-
lection might be defective in IGSF4GT/GT thymocytes.
In contrast, the surface expression of other TCR compo-
nents, such as CD3 and TCR -chain, was similar in WT 
and IGSF4GT/GT thymocytes and splenic T cells (Fig. 7 C). To 
further determine whether thymocytes present in IGSF4GT/GT 
mice are competent for TCR signaling, thymocytes were 
stimulated with anti-mCD3/28 and assessed for phosphoryla-
tion of the TCR -chain and its down-stream signaling path-
ways. The signaling pathways were dramatically attenuated in 
IGSF4GT/GT thymocytes compared with those of IGSF4+/+ 
mice (Fig. 7 D). Consequently, IL-2 production was also re-
duced in IGSF4GT/GT thymocytes (Fig. 7 E).
In accordance with the perturbed thymocyte develop-
ment, the number of CD4+ and CD8+ cells in the spleens and 
lymph nodes of IGSF4GT/GT mice slightly decreased com-
pared with those of IGSF4+/+ mice (Fig. 8 B). Because sur-
face expression of TCR- was similar in WT and IGSF4GT/GT 
spleen T cells (mean fluorescent intensity of TCR-, WT vs. 
IGSF4GT/GT: 12.95 ± 0.77 vs. 11.05 ± 0.21; Fig. 7 C), we 
further determined the TCR signaling in splenic T cells of 
Figure 6.  Generation of IGSF4-deficient 
mice and characterization of phenotype. 
(A) The trap vector, pU-21W, was inserted into 
the first intron of IGSF4. P1-2 (a primer set 
for the trap vector insertion point in the first 
intron; red arrows) and T1-2 (a primer set for 
the trap vector–specific sequence; orange 
arrows) were used for genotyping, and E1-2 
(a primer set for the exon 1– and exon 2–
specific sequence; blue arrows) was used for 
RT-PCR to detect endogenous IGSF4 mRNA. 
(B) PCR genotyping. Genomic DNA was ex-
tracted from mouse ear tissue. The WT (+/+) 
and trap (GT) alleles were detected with P1-2, 
but the homozygote (GT/GT) allele was not 
detected with this primer set (top). Total RNA 
was also extracted from mouse ear tissue, and 
the levels of IGSF4 mRNA were determined by 
using E1-2 (bottom). (C) Phenotypic compari-
son of IGSF4+/+ and IGSF4GT/GT mice. 4-wk-old 
and E18.5 WT and knockout littermates of size 
differences are shown. The organs from the 
IGSF4GT/GT mice are slightly smaller than those 
of the WT littermates (He, heart; Ki, kidney; 
Sp, spleen; Th, thymus). Body weight was 
measured weekly. The data represent the 
mean ± SD (n = 8).2554 IGSF4 enhances T cell activation | Kim et al.
T cells and APCs and has a low affinity for binding between 
identical ectodomains (Shingai et al., 2003), we suggest that 
IGSF4 serves as an initial scanning receptor facilitating the 
exploration of the APC surface by T cells. Montoya et al. 
(2002) suggested a role of ICAM-3 in the early adhesive in-
teractions between T cells and APCs; the clustering of en-
dogenous ICAM-3 at cell–cell contacts occurred in both 
antigen-independent and -dependent T cell–APC inter-
actions in their study. Similarly, IGSF4 clustering occurred rap-
idly after the initial cell–cell contact in our study, suggesting 
its role in early adhesive events. The view is supported by 
the finding that IGSF4-overexpressing cells show increased 
antigen-nonspecific conjugate formation (Fig. 3 B).
The CT domain of IGSF4 includes a couple of important 
motifs that interact with other proteins. One of these is a 
protein 4.1–binding motif in the juxtamembrane portion, 
which  directly  interacts  with  DAL-
1/4.1b, a known spectrin-actin–binding 
protein (Murakami, 2005). The other 
is a PDZ-binding motif, through which 
a  group  of  proteins  belonging  to 
membrane-associated  guanylate  kinase 
homologues (MAGuK) can interact. 
Given that these interacting mole-
cules are important for cytoskeleton 
a severe decrease in IL-2, IFN-, and IL-4 levels in CD4+ 
and CD8+ T cells of IGSF4GT/GT mice stimulated with anti-
mCD3/28 (Fig. 8 G).
DISCUSSION
In this study, we found that IGSF4 is important for T cell 
functioning both in vitro and in vivo. It is expressed in all   
T cell subsets including CD4+ and CD8+ cells as well as in 
other types of cells including B cells and DCs. These facts led 
us to focus on the function of IGSF4 in T cells rather than in 
APCs. We  found  that  IGSF4  enhances T  cell  activation 
through dual independent mechanisms: control of TCR sig-
naling and control of T cell–APC interaction.
The extracellular region of IGSF4 mediates intercellular 
adhesion through homophilic or heterophilic trans-interaction 
in neighboring cells. Because IGSF4 is expressed on both   
Figure 7.  IGSF4GT/GT mice show substan-
tial blockade of intrathymic T cell devel-
opment. (A) Thymocytes were stained with 
FITC-conjugated anti-CD4 and Cy5.5- 
conjugated anti-CD8 mAbs, and then the 
cells were analyzed by flow cytometry. On dot 
plots, the percentage of cells in each quadrant 
is indicated. Mean cell numbers of thymocyte 
subsets are shown in the bar graph (right). 
The results are the mean ± SD of triplicate 
experiments. *, P < 0.05, as compared with 
cells from IGSF4+/+ mice. (B) Flow cytometric 
analysis of TCR-, CD5, and CD69 in IGSF4+/+ 
and IGSF4GT/GT thymocytes. Numbers above 
bracketed lines indicate the percentage of 
TCR-hi, CD69hi, and CD5hi cells. (C) Surface 
expression of CD3, TCR -chain, and TCR- 
on thymocytes or lymphocytes from IGSF4+/+ 
and IGSF4GT/GT. (A–C) Data are representative 
of at least five to six independent experiments.  
(D) Thymocytes from IGSF4+/+ and IGSF4GT/GT 
mice were stimulated with anti-CD3/28 for 
the indicated time. The phosphorylated (p) 
and total (t) forms of Lck, Zap70, ERK, and 
p38 kinase were determined by Western blot 
analysis. Data are representative of two inde-
pendent experiments. Molecular mass (M) is 
indicated in kilodaltons. (E) Thymocytes were 
stimulated with anti-CD3/28 for the indicated 
time, and the cytokine productions (IL-2) were 
measured by ELISA. The results are the mean 
± SD of triplicate experiments. *, P < 0.05, as 
compared with cells from IGSF4+/+ mice.JEM Vol. 208, No. 12 
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Figure 8.  IGSF4GT/GT mice show defective T cell function. (A) IGSF4 expression in purified CD3+ T cells from the spleens and lymph nodes of WT and 
IGSF4GT/GT mice. Molecular mass (M) is indicated in kilodaltons. (B) The number of each cell type in the lymph node and spleen. The results are the mean ± SD 
of triplicate experiments. *, P < 0.05, as compared with IGSF4+/+ mice. (C) T cells purified from the spleen were stimulated with anti-CD3/28 for the indicated 
time. The phosphorylated (p) and total (t) forms of Lck, Zap70, ERK, and p38 kinase were determined by Western blot analysis. Data are representative of three 
independent experiments. (D) Allogeneic DCs and CD3+ T cells from WT or IGSF4GT/GT mice were incubated in SEB-containing medium for 3 h to allow conju-
gation. The cells were fixed and stained with anti–p-tyrosine (4G10; arrows). Polarization of p-tyrosine in T cells was quantified by cell counting (n > 50). Data 
are representative of at least three independent experiments. DIC, differential interference contrast. (E) CD3+ T cells were mixed with SEB-pulsed CD11C+ DCs 
(red) or CD19+ B cells from WT mice, and then conjugate formation was determined by confocal microscopy (left) and flow cytometry (bar graphs). (F) Purified 
splenic CD3+ T cells from WT and IGSF4GT/GT mice were incubated with anti-CD3/28 for 72 h. Cell proliferation was assessed by [3H]thymidine incorporation. 
(G) CD4+ or CD8+ T cells were stimulated with anti-CD3/28 or PMA/A23187 for 24 h, and the cytokine productions (IL-2, IL-4, and IFN-) were measured by 
ELISA. (E–G) The results are the mean ± SD of triplicate experiments. *, P < 0.05, as compared with cells from IGSF4+/+ mice. Bars: (D) 5 µm; (E) 10 µm.
rearrangement, the CT domain may transmit the signal of 
cell adhesion toward cytoskeleton organization by modulat-
ing actin networks or cellular polarity. However, the CT   
domain had little function at least in synapse accumulation 
and T cell activation, although it appears to be multifunc-
tional in other cell types, especially epithelial cells (Shingai 
et al., 2003). There are two possible explanations for the lack 
of CT domain function. First, IGSF4 could interact with the 2556 IGSF4 enhances T cell activation | Kim et al.
because  functions  of  IGSF4  are  strikingly  distinguishable 
from those of CRTAM, an adhesion molecule transiently 
expressed on activated CD4+ T and CD8+ T cells (Abbas 
et al., 2005). CRTAM/ mice showed no signs of thymic 
developmental defects, and the positive selection was normal 
(Yeh et al., 2008). In addition, CRTAM mediated only the 
maintenance of late-phase T cell polarity corresponding to 
the selective production of IFN- and IL-22. In contrast to 
CRTAM/ mice, however, the defect of early T cell devel-
opment in IGSF4GT/GT thymocytes strongly suggests that the 
physiological action of IGSF4 in T cells does not overlap 
with that of CRTAM. Although it has been suggested that 
IGSF4 serves only as a ligand for CRTAM in APCs, our 
present results unambiguously demonstrate that IGSF4 plays 
a unique role in T cell immunity.
The thymus provides a specialized microenvironment for 
T cell development and many components are involved in 
thymocyte development, including ECM integrin and laminin 
in thymic epithelial cells (Magner et al., 2000; Schmeissner   
et al., 2001). Thus, it will be of interest to address whether 
IGSF4 has another binding partner rather than a homophilic 
interaction with IGSF4 on thymic epithelial cells or DCs. Re-
cently, Garay et al. (2010) demonstrated that CRTAM is also 
detected in epithelial cells along the lateral membrane and is 
important for early cell–cell contacts and cell–substrate inter-
actions. Therefore, reverse configuration, i.e., IGSF4-CRTAM 
rather than CRTAM-IGSF4, may correspond to early T cell 
development and positive selection in the thymus.
In conclusion, IGSF4 is a novel -chain–associating pro-
tein and a key regulator of T cell responses from early to late 
phases. Two independent mechanisms of its function coexist. 
As an intercellular adhesion molecule, IGSF4 has an adhe-
sion-dependent co-stimulatory function through homophilic 
or  heterophilic  interactions  with  ligands  on  APCs.  This 
mechanism may be important for the initiation of T cell con-
tact with epithelial cells in the thymus or DCs in the lym-
phoid tissues as well as for the formation and maintenance of 
the immunological synapse. As a binding partner of the -chain, 
it enhances the transmission of outside signals to the inside of 
cells by modulating phosphorylation of the -chain, down-
stream proximal kinases such as Lck and Zap70, and distal 
MAP kinases such as ERK and p38 kinase. In this study, we 
evidenced the role of IGSF4 in T cell development and acti-
vation. IGSF4 may also have roles in a variety of effector 
functions including Th1/Th2/T-reg responses and cytotoxic 
T cell or NKT cell responses. In addition, it may be involved 
in immune function–related diseases such as cancer, infec-
tious diseases, shock, and autoimmune diseases as well as im-
mediate and delayed hypersensitivity reactions through its 
action in activating T cell immunity.
MATERIALS AND METHODS
Mice, reagents, and antibodies. C57BL/6 WT, TCR transgenic DO11.10, 
and C57BL/6 IGSF4+/GT heterozygous mice were obtained from Damul Sci-
ence, the Jackson Laboratory, and Kumamoto University, respectively. The 
mice were housed in specific pathogen–free conditions, and all experiments 
were approved by the Animal Care and Use Committee of the School of Life 
TCR -chain through only the TM domain, which regulates 
its phosphorylation; in this case, the CT domain is not re-
quired for this signaling cascade. Second, although the CT 
domain  can  bind  to  DAL-1,  CASK,  MPP6  (Pals2),  and 
MPP3 (Biederer et al., 2002; Fukuhara et al., 2003; Shingai 
et al., 2003), no specific function of these molecules has been 
reported in T cells since they were discovered; these mol-
ecules are mainly involved in suppressing tumorigenesis 
(Fukuhara et al., 2003) and maintaining epithelial morphol-
ogy (Shingai et al., 2003).
Surprisingly, we observed that IGSF4 interacts with the 
TCR -chain and this interaction is mediated by the TM 
domain. Indeed, replacement of the IGSF4 TM domain by 
the CD43 TM domain resulted in loss of -chain association 
and the subsequent phosphorylation of the -chain and down-
stream signaling pathways. However, it is unclear how the 
IGSF4 TM domain associates with the -chain and controls 
its phosphorylation. As we observed no association of IGSF4 
with cytosolic tyrosine kinases such as Lck and Zap70 in un-
stimulated conditions, the interaction with the -chain may 
be extremely dependent on a TM–TM interaction. It is 
well characterized that the -chain contains the homodimeric 
motif (LxxxxGVxxT) in the TM domain that participates in 
the TCR/CD3 complex assembly by interacting with CD3 
TM domains (Bolliger and Johansson, 1999). This motif may 
also mediate the interaction of the -chain with the specific 
region of IGSF4 TM domain. Interestingly, IGSF4 contains 
a GxxVx sequence, which is similar to the dimerization motifs 
in the TM domain of tyrosine kinase growth factor receptors 
such as Ltk (mouse leukocyte tyrosine kinase; GxxVx) and 
EGFR (epidermal growth factor receptor; SxxVx; Sternberg 
and Gullick, 1990). Therefore, it will be interesting to inves-
tigate whether the GxxVx motif mediates the heterodimeric 
interaction with the -chain and thus enhances TCR signal-
ing. The interaction may be important in TCR microcluster 
formation (Yokosuka and Saito, 2010). The signaling com-
plexes including Lck, Zap70, and LAT are known to be re-
cruited rapidly to the microclusters (Yokosuka and Saito, 
2010). Interestingly, in a related study, we found that Lck and 
Zap70 were highly concentrated at the region that IGSF4 
was polarized in IGSF4-overexpressing cells, suggesting that 
IGSF4 is involved in clustering of the TCR complex by inter-
acting with the -chain and, consequently, that the size and 
number of microclusters increase.
Our genetic experiments in mice revealed that IGSF4 is 
involved  in  thymocyte  positive  selection  and  maturation. 
The developmental defect was also associated with less ex-
pression of CD5, CD69, and TCR- in IGSF4GT/GT thymo-
cytes, which is regulated by TCR signaling (Azzam et al., 
1998). Impaired TCR signaling in IGSF4GT/GT T cells was 
further demonstrated by less proliferation and less activation 
of kinase signaling cascades in response to TCR engagement. 
In addition, a dramatic reduction of effector T cell functions 
in  terms  of  cytokine  production  strongly  suggested  that 
IGSF4 serves as a positive regulator for thymocyte development 
and TCR signaling. These results are particularly interesting JEM Vol. 208, No. 12 
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70 µM siRNAs or 2 µg/100 µl shRNAs were introduced into the target cells 
and cultured for 48 h before use.
cDNA constructs. DNA fragments encoding human WT IGSF4 or dele-
tion or swapping mutants were generated by PCR from a full-length IGSF4 
ORF clone (imaGenes GmbH) and inserted into pEGFP-N1 (Takara Bio 
Inc.) or pHJ-1 lentiviral vector. The expression vectors for various mutants 
of IGSF4 were as follows: IGSF4/CT (deletion of the entire CT domain, 
398–442), IGSF4/PDZ (deletion of the PDZ binding motif, 432–442), 
IGSF4/EXT  (deletion  of  the  entire  extracellular  domain,  1–373), 
IC1_IGSF4 (the extracellular domain was substituted with D3–5 of ICAM-1), 
IGSF4/CD43TM (the TM domain was substituted with the TM domain of 
CD43), and IGSF4/EXT/CD43TM (IGSF4/EXT + IGSF4/CD43TM). 
All the IGSF4 deletion and chimeric mutants were verified by sequencing 
analysis. TCR -chain cDNA was amplified from the -chain mRNA by 
RT-PCR using primers 5-ATGAAGTGGAAGGCGCTTTTCACCGC-
GGCC-3 and 5-TTAGCGAGGGGGCAGGGCCTGCATGTGAAG-3, 
and then the PCR product was inserted into pERFP_N1 to generate 
TCR _RFP.
RT-PCR and real-time quantitative RT-PCR. Total RNA was iso-
lated from cells or homogenized tissues of C57BL/6 mice with TRIZOL 
reagent and reverse transcribed by using RT-PreMix (iNtRON Biotechnol-
ogy). PCR was performed with the following primers (the respective for-
ward and reverse pairs are indicated): human IL-2, 5-CACGTCTTGCACTT-
GTCAC-3 and 5-CCTTCTTGGGCATGTAAAACT-3; mouse IL-2, 
5-TGAGCAGGATGGAGAATTACAGG-3and 5-GTCCAAGTTCATC-
TTCTAGGCAC-3; human GAPDH, 5-CGGAGTCAACGGATTTGGT-
CGTAT-3 and 5-AGCCTTCTCCATGGTGGTGAAGAC-3; mouse 
GAPDH, 5-GCACAGTCAAGGCCGAGAAT-3 and 5-GCCTTCTC-
CATGGTGGTGAA-3; human IGSF4, 5-AAGTAGTCCTGAAGGAC-
AGAAACT-3 and 5-ATAAATCAGCATAAGTTTTCCACA-3; mouse 
IGSF4, 5-CAGTATAAACCGCAAGTGCA-3 and 5-GCGGTAAGT-
ACCGTTATCTG-3;  human  Necl1,  5-AGCCCATCATCACTGGT-
TATAAAT-3 and 5-TTTACCATTGGGATCTTCCTGTAT-3; human 
nectin3, 5-GTTCAAGGAGAATATCAGGGAAGA-3 and 5-TAAGAA-
CTGCCCTTTTCAG-3; and human CRTAM, 5-GTAATACTACCAG-
CACTCTCATAATCCAC-3 and 5-GATGTACTAGAATCTTCCGT-
TACTGAGAC-3. The amplification profile was composed of denaturation 
at 94°C for 30 s, annealing at 60°C for 20 s, and extension at 72°C for 40 s. 
The 30 cycles were preceded by denaturation at 72°C for 7 min.
Total RNA was isolated, and cDNA was synthesized. PCR amplifica-
tion was performed in DNA Engine Opticon1 (MJ Research) for continu-
ous  fluorescence  detection  in  a  total  volume  of  10  µl  containing  1  µl 
cDNA/control and gene-specific primers by using SYBR Premix Ex Taq 
(Takara Bio Inc.). The mRNA levels of the target genes, relative to GAPDH, 
were normalized by using the following formula: relative mRNA expression = 
2(Ct of target gene  Ct of GAPDH), where Ct is the threshold cycle value. In each 
sample, the expression of the gene being analyzed was normalized to that of 
GAPDH and described as the relative mRNA levels to GAPDH or percent-
age of maximum.
T  cell  stimulation.  Jurkat  T  cells  (including  IGSF4-overexpressing  or 
knockdown cells) and mouse CD3+ T cells (including CD4+ or CD8+ cells) 
were stimulated with either plate-bound anti-CD3 (10 µg/ml OKT3 for 
human; 10 µg/ml 145-2C11 for mouse)/2 µg/ml CD28 or 200 nM PMA/1 µM   
A23187. For superantigen stimulation, Jurkat T cells were incubated with 
1 µg/ml SEE–pulsed Raji B cells. Mouse T cells were incubated with   
1 µg/ml SEB–pulsed mouse DCs (CD11C+) or B cells (CD19+). Splenic 
CD3+ T cells from TCR transgenic DO11.10 mice were stimulated with 
50 ng/ml OVA–pulsed A20 B cells.
Immunofluorescence and confocal imaging analyses. For live-time 
colocalization analysis, Jurkat T cells expressing GFP or WT IGSF4_GFP 
were stained with anti–CD3-Fab-cy3, anti–CD45-Fab-cy3, or LFA-1–Fab-cy3 
Sciences, Gwangju Institute of Science and Technology. OmicsLink shRNA 
expression clone against IGSF4 was obtained from GeneCopoeia, and siRNA 
targeting IGSF4 and a scrambled siRNA were obtained from Thermo Fisher 
Scientific. SEE and SEB were obtained from Toxin Technology. OVA pep-
tide fragments (323–339) were purchased from GeneScript Corp. Colchicine, 
PMA, A23187, and PLL were purchased from Sigma-Aldrich. Anti-CD3/28 
Dynabeads and fluorescent dyes for cell labeling, green CMFDA (5-chloro-
methylfluorescein diacetate) and orange CMRA, were obtained from Invitro-
gen. [3H]thymidine was obtained from PerkinElmer. Welprep Total RNA 
isolation reagent, reverse transcript PCR premix, conventional PCR premix, 
and ECL Western blotting detection reagents were purchased from iNtRON 
Biotechnology. ECL advanced detection kit (Lumigen TMA-6) was pur-
chased from GE Healthcare. PrimeSTAR HS DNA polymerase was purchased 
from Takara Bio Inc. ImmunoPure Fab preparation kit was obtained from 
Thermo Fisher Scientific, and Cy-3 bisfunctional dye kit was obtained from 
GE Healthcare. Duo Set mouse IL-2, IL-4, and IFN- ELISA kits and a 
mouse T cell enrichment column were obtained from R&D Systems. Anti–
human CD28 was purchased from R&D Systems, and anti–mouse CD28 was 
purchased from BD. OKT3 (human anti-CD3; CRL-8001) and 145-2C11 
(mouse anti-CD3; CRL-1975) hybridoma cell lines were purchased from the 
American Type Culture Collection. TS1/18 (anti–human LFA-1; HB-203) 
and R6.5 (anti–human ICAM1) hybridoma cell lines were a gift from T.A. 
Springer (Harvard Medical School, Boston, MA). Rabbit polyclonal anti-GFP 
was developed in rabbit by using purified recombinant full-length GFP pro-
tein (AbFrontier). Anti–human IGSF4, anti–TCR -chain (6B10.2), anti–
CD3  chain  (C-20),  anti–CD3  chain  (M-20),  anti-CD3  (M-20), 
anti–TCR- (H-142), anti–TCR- (H-197), FITC-conjugated anti-CD43 
(6D269), mouse polyclonal anti-GFP, and goat polyclonal anti–-actin were 
purchased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal anti–p-
Zap70, rabbit anti-Zap70 (99F2), rabbit polyclonal anti-Lck, rabbit polyclonal 
anti–p-Lck,  rabbit  anti-p44/42  MAPK  (137F5),  rabbit  anti–p-p44/42 
(197G2), rabbit polyclonal anti-p38, rabbit anti–p-p38 (3D7), horseradish per-
oxidase–conjugated  anti–mouse  IgG,  and  anti–rabbit  IgG  were  purchased 
from Cell Signaling Technology. Phosphorylated tyrosine (4G10) was pur-
chased from Millipore. Mouse anti-p–CD3- (K25-407.69) and mouse anti-
CD45 (2D1) were purchased from BD. FITC-conjugated anti–mouse CD4, 
PerCP  Cy5.5–conjugated  CD8,  FITC-conjugated  anti–mouse  TCR-, 
FITC-conjugated anti–mouse CD5, PE-conjugated CD3, PE-conjugated 
TCR , and PE-conjugated anti-CD69 were purchased from eBioscience. 
Secondary antibodies including FITC-conjugated anti–rabbit IgG, anti–goat 
IgG, and anti–hamster IgG were purchased from Sigma-Aldrich.
Cells. Jurkat T cells (TIB-152; American Type Culture Collection), HuT78 
(TIB-161; American Type Culture Collection), Molt4 (CRL-1582; Ameri-
can Type Culture Collection), J77 (TIB-67; American Type Culture Col-
lection), HEK293T (CRL-1573; American Type Culture Collection), and 
Raji B cells (gift from F. Sánchez-Madrid, Universidad Autónoma de 
Madrid, Madrid, Spain) were maintained in RPMI 1640 medium (Invitrogen) 
supplemented with 10% (vol/vol) FBS (Invitrogen). After written informed 
consent, human primary PBLs were isolated from healthy donors by dextran 
sedimentation and centrifugation through a discontinuous Ficoll gradient 
(GE Healthcare). Human PBLs and mouse splenocytes were dispersed and 
purified to CD4+, CD8+, CD19+, and CD11C+ populations by MACS cell 
separation (Miltenyi Biotec). All mouse CD3+ T cells were purified from the 
mouse spleen and lymph nodes on a T cell enrichment column (BD). The 
purity of each population was confirmed to be >95% by flow cytometry.
Cell transfection and lentiviral infection. Transient transfection to Jurkat   
T cells was mostly performed by Amaxa technology using Nucleofector kitV 
(Lonza). Transfection to 293T cells was performed by using Lipofectamine 
2000 (Invitrogen). To establish stable cell lines, cDNAs in pHJ-1 lentiviral 
vector were cotransfected with lentiviral packaging vectors (pHDM-Hgpm2, 
1 pRC/CMV-Rev1b, and pHDM.G) into 293T cells. The supernatants 
were collected and spin-infected into Jurkat T cells by centrifugation at 800 g 
for 30 min in the presence of 8 µg/ml polybrene. For IGSF4 knockdown, 2558 IGSF4 enhances T cell activation | Kim et al.
IGSF4 immunoprecipitates, cells were lysed in 0.3% CHAPS lysis buffer 
instead of 1% Triton X-100.
Western blotting. Cells or tissue samples were lysed in Triton X-100 lysis 
buffer containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, one tablet of 
Complete protease inhibitors, and phosphatase inhibitors (cocktails I and II). 
The lysates were centrifuged at 14,000 rpm for 25 min at 4°C, and the 
supernatant was eluted with SDS sample buffer (100 mM Tri-HCl, pH 6.8, 4% 
SDS, and 20% glycerol with bromophenol blue) and heated for 5 min. The 
proteins were separated through 10% SDS-PAGE gels and transferred onto 
a nitrocellulose membrane (GE Healthcare) by means of Trans-Blot SD 
semidry transfer cell (Bio-Rad Laboratories). The membrane was blocked in 
5% skim milk for 1 h at room temperature, rinsed, and incubated with the 
intended antibodies in TBS containing 0.1% Tween 20 (TBS-T) and 3% 
skim milk for 2 h at room temperature. Excess primary antibody was then 
removed by washing the membrane four times in TBS-T. The membrane 
was then incubated with 0.1 µg/ml peroxidase-labeled secondary antibody 
(anti–rabbit or anti–mouse) for 2 h at room temperature. After three washes 
in TBS-T, bands were visualized by using ECL Western blotting detection 
reagents (iNtRON Biotechnology) and exposed onto x-ray film. In some 
cases, the detection sensitivity was improved by using the ECL advanced de-
tection kit (Lumigen TMA-6; GE Healthcare).
ELISA. Splenic CD3+ T cells, CD4+ or CD8+ T cells, or thymocytes (5 × 
104 cells/sample) were stimulated as described in the section T cell stimula-
tion. After 24–48 h, the amounts of IL-2, IL-4, and IFN- in supernatants 
from three replicas for each condition were determined by ELISA with Duo 
Set Mouse ELISA kits for IL-2, IL-4, and IFN- (R&D Systems).
Flow cytometry and determination of cell number. Thymus, spleen, 
and lymph nodes were excised from mice, and single-cell suspensions were 
obtained by mincing the organs through a nylon mesh. Isolated cells were 
stained for flow cytometry with antibodies against CD4, CD8, CD69, CD5, 
TCR-, TCR -chain, and CD3 for 30 min at 4°C. Total cellularity was 
determined by counting the live cells. Absolute cell numbers were calculated 
on the basis of the percentage of each population and represented as the 
mean ± SD. The mice in these experiments were 4 wk of age.
Mice  strains  and  genotyping.  A  C57BL/6  IGSF4+/GT  heterozygous 
mouse was generated by a group at Kumamoto University. In brief, ex-
changeable gene trap pU-21W vector was used for random gene trap muta-
genesis. The mutant construct contains a splice acceptor sequence linked to 
the -geo reporter gene, and its integration site is concentrated in the 5 end 
of the trapped gene. The pU-21W vector (20–40 µg) was transfected by 
electroporation (800 V, 3 µF with Gene Pulser; Bio-Rad Laboratories) into 
feeder-free embryonic stem (ES) cell line KTPU8 (F1 of B6 and CBA). 
Thereafter, G418-resistant clones were selected and expanded. Genomic 
DNA was prepared from the clones and examined by PCR and Southern 
blotting for single-copy integration and for the existence of lox71–lox2272 
sites, which are indispensable for site-specific recombination. To identify the 
trapped gene, 5-RACE was performed. We found that pU-21W was in-
serted at 212,677 bp downstream of IGSF4 exon 1. Clones that had the 
trapped gene insertion in IGSF4 were used to generate chimeric mice. ES 
cells were aggregated with morulae from ICR (imprinting control region) 
mice; 125 morulae per line were used and transferred into five foster moth-
ers. The chimeric mice were mated with C57BL/6 females. Genomic DNAs 
of the F1 progenies and original ES cells were subjected to Southern blotting 
to confirm identical integration of the vector in the mouse line and the 
original ES clone. The strain name is depicted as B6;CB-Cadm1Gt(pU-
21W)34Imeg, and the address of the Database for the Exchange of Gene 
Trap Clones is http://egtc.jp/action/access/clone_detail?id=21-W34.
T cell proliferation assay. Mouse splenocytes were enriched by using a   
T cell enrichment column (BD), and 5 × 104 cells/sample were incubated 
for 72 h on 10 µg/ml anti-CD3–coated 96-well plates or 5 µg/ml PHA in 
for 1 h at 4°C and then incubated for 15–30 min with SEE-pulsed Raji   
B cells stained with Cell Tracker orange CMRA (Invitrogen) or anti–ICAM-
1–Fab-cy5 in a live chamber device. CD43 was stained with anti–CD43-
Fab-FITC. 1 µg/ml colchicine (or vehicle [DMSO]) was treated before   
T cell–B cell conjugation. For translocation analysis, Jurkat T cells expressing 
WT IGSF4_GFP or other mutants were incubated for 30 min at 37°C on 
PLL- or anti-CD3–coated coverslips or with anti-CD3/28–coated Dyna-
beads (Invitrogen). IGSF4 accumulation at the T cell–APC contact site or 
anti-CD3–coated surface was calculated as the ratio of fluorescence intensity 
at the contact region (Fcon = a) to the fluorescence intensity at the opposite 
site (Foppo = b). In some cases, the percentage of T–T or T–B conjugates 
with surface IGSF4 relocation at the contact zone relative to the total num-
ber of conjugates in the absence or presence of SEE was also analyzed from 
a total of 150 conjugates of each category (Figs. 2 A and 3 C).
In the mouse experiment, purified mouse CD3+ T cells were co-cultured 
with SEB-pulsed allogeneic DCs or B cells on PLL-coated glass, fixed, and 
stained with anti–p-tyrosine. The data were obtained, processed, and ana-
lyzed  by  FLUOVIEW  software  (Olympus).  The  z-section  cutting  area 
through the apical surface was chosen for the colocalization analysis. Fluores-
cence was represented by an intensity profile with blue indicating the lowest 
intensity and red indicating the highest intensity.
Quantitation of cell aggregation. J-GFP or J-IGSF4_GFP cells were 
cultured at the concentration of 2 × 105 cells/well in the presence or absence 
with anti-CD3/28 for 3 h. Aggregate formation was quantitated by phase-
contrast microscopy using a calibrated ocular grid as described previously 
(Dang and Rock, 1991). The percentage of cells forming aggregates was de-
termined by counting free cells within the grid in six randomly selected grids 
within one well and then applying the following equation: percent aggrega-
tion = (1  number of free cells/number of total cells) × 100.
Conjugation assay. Raji B cells, mouse DCs (CD11C+), or mouse B cells 
(CD19+) were stained with Cell Tracker orange CMRA according to the 
manufacturer’s directions, incubated in the presence or absence of superanti-
gen (1 µg/ml SEE for human and 1 µg/ml SEB for mouse) for 30 min, 
washed, and resuspended at a density of 106 cells/ml in RPMI. Jurkat or 
mouse CD3+ T cells were stained with Cell Tracker green CMFDA (Invit-
rogen) and resuspended at a density of 106 cells/ml in RPMI. For T cell–
APC conjugation, equal volumes of T cells and APCs were mixed together 
and incubated at 37°C for 30 min. The relative proportion of red, green, and 
red-green populations was determined by an EPICS XL flow cytometer 
(Beckman Coulter). The number of gated events counted per sample was at 
least 10,000.
Immunoprecipitation. For immunoprecipitation, Jurkat T cells (includ-
ing WT IGSF4– or IGSF4 mutant–overexpressing cells) were incubated at 
2 × 107 cells/ml in the presence or absence of anti-CD3/28 for 30 min. 
The cells were washed quickly once in cold PBS and lysed in 1% Triton   
X-100 lysis buffer containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, one 
tablet of Complete protease inhibitors (Roche), and phosphatase inhibitors 
(cocktails I and II; Sigma-Aldrich). The lysates of equivalent protein con-
tent were precleared on Sepharose 4B (GE Healthcare) for 1 h at 4°C. 
GFP-fused IGSF4 and mutant proteins or TCR -chain was immunopre-
cipitated with anti-GFP–conjugated Sepharose 4B or anti–TCR -chain–
conjugated protein A/G agarose. Immunoprecipitates were washed twice 
with the corresponding 1% Triton X-100 lysis buffer and twice with lysis 
buffer without detergent. Proteins were resolved by 10–12% SDS-PAGE, 
and then Western blot analysis was performed as described in the next sec-
tion. To analyze the direct binding of TCR -chain with IGSF4, HEK293T 
cells were cotransfected with TCR _RFP and IGSF4_GFP. The cells were 
lysed as above, and immunoprecipitation was performed using antibodies 
against GFP (for IGSF4) and TCR -chain. The amount of TCR -chain 
or IGSF4 present in the immunoprecipitates was analyzed by Western blot 
analysis as described in the next section. For detection of the TCR com-
plex ( and , CD3, CD3, CD3, and TCR ) and Zap70 and Lck in JEM Vol. 208, No. 12 
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RPMI 1640 medium containing 10% FBS. [3H]thymidine was added at   
1 µCi/well 14 h before measurement. The cells were harvested, and [3H] ra-
diation was measured by liquid scintillation.
Body weight measurement. 4-wk-old mice were sacrificed, and their 
heart, kidney, spleen, thymus, and lymph node were removed and displayed. 
Heterozygous female mice crossed with a heterozygous male were sacrificed 
at day 18.5 after checking the vaginal plug. Embryonic day 18.5 (E18.5) em-
bryos were isolated and photographed. All embryos were used for geno-
typing. All mice were weighed at 1-wk intervals from 4 to 8 wk of age.
Statistical analysis. Data represent the mean ± SD of three or more indepen-
dent experiments conducted on separate days. Unpaired Student’s t test and 
one-way analysis of variance were used for statistical analysis (P < 0.05).
Online supplemental material. Video 1 reveals the c-SMAC localization 
of IGSF4_GFP in the T cell–B cell conjugates. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20110853/DC1.
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